Invention Grant
- Patent Title: Anti-PD-L1 nanobody, coding sequence and use thereof
-
Application No.: US16085899Application Date: 2017-03-17
-
Publication No.: US10556954B2Publication Date: 2020-02-11
- Inventor: Hong Hoi Ting , Chung Lim Wong
- Applicant: NANOMAB TECHNOLOGY LIMITED
- Applicant Address: CN Hong Kong
- Assignee: NANOMAB TECHNOLOGY LIMITED
- Current Assignee: NANOMAB TECHNOLOGY LIMITED
- Current Assignee Address: CN Hong Kong
- Agency: McCarter & English, LLP
- Agent Marcie B. Clarke; Weiguo Zhou
- Priority: CN201610158493 20160318
- International Application: PCT/CN2017/077122 WO 20170317
- International Announcement: WO2017/157334 WO 20170921
- Main IPC: A61P35/00
- IPC: A61P35/00 ; C07K16/28 ; C07K16/06 ; C12N15/62 ; C12N15/85
Abstract:
Provided in the present invention are a type of anti-human PD-L1 specific nanobodies and VHH chains thereof, coding sequences of the foregoing nanobodies or VHH chains thereof, corresponding expression vectors and host cells, and a method for producing antibodies.
Public/Granted literature
- US20190177416A1 ANTI-PD-L1 NANOBODY, CODING SEQUENCE AND USE THEREOF Public/Granted day:2019-06-13
Information query
IPC分类:
| A | 人类生活必需 |
| A61 | 医学或兽医学；卫生学 |
| A61P | 化合物或药物制剂的特定治疗活性 |
| A61P35/00 | 抗肿瘤药 |
